Hard To Treat Diseases
HTDS · OTC
$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
About HTDS
- Employees
- 0
- Headquarters
- Clearwater, Florida
- Listed
- Jun 21, 2001
- Sector
- Industrials
- Industry
- Commercial Services & Supplies
- Website
- htdsmedical.com
HTDS key statistics
- Market cap
- 5.48K
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 1.11M
- Volume
- 169.36K
- Open price
- $0.00
- High today
- $0.00
- Low today
- $0.00
- 52 Week high
- $0.00
- 52 Week low
- $0.00
Hard To Treat Diseases (HTDS) at a glance
Hard To Treat Diseases (HTDS) last traded at $0.00, with a market cap of 5.48K.
Volume so far is 169.36K shares, below the average of 1.11M shares a day.
Similar companies
Companies in the same industry as Hard To Treat Diseases
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.